Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Sep;62(9):880–884. doi: 10.1136/ard.62.9.880

Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis

T Yli-Kerttula 1, R Luukkainen 1, U Yli-Kerttula 1, T Mottonen 1, M Hakola 1, M Korpela 1, M Sanila 1, J Uksila 1, A Toivanen 1
PMCID: PMC1754652  PMID: 12922963

Abstract

Background: The value of antibiotics in the treatment of reactive arthritis (ReA) is still controversial.

Objectives: To analyse the long term outcome of patients with ReA, treated with a three month course of ciprofloxacin or placebo.

Methods: Patients who had had ReA and had participated in a double blind, placebo controlled trial on the effectiveness of ciprofloxacin 4–7 years earlier were invited to a clinical examination. Of the 71 patients who were included in the original study, 53 agreed to visit the clinic for an examination. Twenty six of 53 patients had originally received ciprofloxacin and 27 had belonged to the placebo group. Of these, 20 in the ciprofloxacin and 25 in the placebo group were HLA-B27 positive.

Results: 11/27 (41%) patients in the original placebo group had now developed chronic rheumatic disease, as compared with only 2/26 (8%) patients originally treated with ciprofloxacin (p=0.006). Two patients who originally had received placebo, none in the ciprofloxacin group had developed ankylosing spondylitis, and three patients in the original placebo group, none in the ciprofloxacin group had recurrent anterior uveitis. The same tendency was seen when several different measures were analysed. Of the patients with chronic spondyloarthropathy, 10 in the placebo and none in the ciprofloxacin group were HLA-B27 positive.

Conclusion: Analysis 4–7 years after the initial ReA suggests that a three month course of antibiotics in the acute phase may have a beneficial effect on the long term prognosis.

Full Text

The Full Text of this article is available as a PDF (68.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardin T., Enel C., Cornelis F., Salski C., Jorgensen C., Ward R., Lathrop G. M. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum. 1992 Feb;35(2):190–194. doi: 10.1002/art.1780350210. [DOI] [PubMed] [Google Scholar]
  2. Bleehen S. S., Everall J. D., Tighe J. R. Amyloidosis complicating Reiter's syndrome. Br J Vener Dis. 1966 Jun;42(2):88–92. doi: 10.1136/sti.42.2.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Caughey D. E., Wakem C. J. A fatal case of Reiter's disease complicated by amyloidosis. Arthritis Rheum. 1973 Sep-Oct;16(5):695–700. doi: 10.1002/art.1780160515. [DOI] [PubMed] [Google Scholar]
  4. Csonka G. W. Long-term follow-up and prognosis of Reiter's syndrome. Ann Rheum Dis. 1979;38 (Suppl 1):suppl–28. doi: 10.1136/ard.38.suppl_1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., Cats A., Dijkmans B., Olivieri I., Pasero G. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991 Oct;34(10):1218–1227. doi: 10.1002/art.1780341003. [DOI] [PubMed] [Google Scholar]
  6. Ekman P., Kirveskari J., Granfors K. Modification of disease outcome in Salmonella-infected patients by HLA-B27. Arthritis Rheum. 2000 Jul;43(7):1527–1534. doi: 10.1002/1529-0131(200007)43:7<1527::AID-ANR17>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  7. Frydén A., Bengtsson A., Foberg U., Svenungsson B., Castor B., Kärnell A., Schvarcz R., Lindblom B., Kihlström E. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. BMJ. 1990 Dec 8;301(6764):1299–1302. doi: 10.1136/bmj.301.6764.1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Granfors K., Jalkanen S., Lindberg A. A., Mäki-Ikola O., von Essen R., Lahesmaa-Rantala R., Isomäki H., Saario R., Arnold W. J., Toivanen A. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 1990 Mar 24;335(8691):685–688. doi: 10.1016/0140-6736(90)90804-e. [DOI] [PubMed] [Google Scholar]
  9. Granfors K., Jalkanen S., Toivanen P., Koski J., Lindberg A. A. Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol. 1992 Mar;19(3):500–500. [PubMed] [Google Scholar]
  10. Granfors K., Jalkanen S., von Essen R., Lahesmaa-Rantala R., Isomäki O., Pekkola-Heino K., Merilahti-Palo R., Saario R., Isomäki H., Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med. 1989 Jan 26;320(4):216–221. doi: 10.1056/NEJM198901263200404. [DOI] [PubMed] [Google Scholar]
  11. Hammer M., Nettelnbreker E., Hopf S., Schmitz E., Pörschke K., Zeidler H. Chlamydial rRNA in the joints of patients with Chlamydia-induced arthritis and undifferentiated arthritis. Clin Exp Rheumatol. 1992 Jan-Feb;10(1):63–66. [PubMed] [Google Scholar]
  12. Hannu T., Mattila L., Siitonen A., Leirisalo-Repo M. Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection. Ann Rheum Dis. 2002 Mar;61(3):264–266. doi: 10.1136/ard.61.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hoogkamp-Korstanje J. A., Moesker H., Bruyn G. A. Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis. Ann Rheum Dis. 2000 Nov;59(11):914–917. doi: 10.1136/ard.59.11.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hoogkamp-Korstanje J. A., de Koning J., Heesemann J. Persistence of Yersinia enterocolitica in man. Infection. 1988 Mar-Apr;16(2):81–85. doi: 10.1007/BF01644307. [DOI] [PubMed] [Google Scholar]
  15. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med. 1983 Dec 29;309(26):1606–1615. doi: 10.1056/NEJM198312293092604. [DOI] [PubMed] [Google Scholar]
  16. Konttinen Y., Nordström D., Bergroth V., Leirisalo-Repo M., Santavirta S. Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow up study. Br Med J (Clin Res Ed) 1988 Jun 11;296(6637):1644–1645. doi: 10.1136/bmj.296.6637.1644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lahesmaa-Rantala R., Granfors K., Isomäki H., Toivanen A. Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis. 1987 Jul;46(7):510–514. doi: 10.1136/ard.46.7.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Laivoranta S., Ilonen J., Tuokko J., Luukkainen R., Toivanen A. HLA frequencies in HLA-B27 negative patients with reactive arthritis. Clin Exp Rheumatol. 1995 Sep-Oct;13(5):637–640. [PubMed] [Google Scholar]
  19. Lauhio A., Leirisalo-Repo M., Lähdevirta J., Saikku P., Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum. 1991 Jan;34(1):6–14. doi: 10.1002/art.1780340103. [DOI] [PubMed] [Google Scholar]
  20. Leirisalo-Repo M., Helenius P., Hannu T., Lehtinen A., Kreula J., Taavitsainen M., Koskimies S. Long-term prognosis of reactive salmonella arthritis. Ann Rheum Dis. 1997 Sep;56(9):516–520. doi: 10.1136/ard.56.9.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Leirisalo M., Skylv G., Kousa M., Voipio-Pulkki L. M., Suoranta H., Nissilä M., Hvidman L., Nielsen E. D., Svejgaard A., Tilikainen A. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum. 1982 Mar;25(3):249–259. doi: 10.1002/art.1780250302. [DOI] [PubMed] [Google Scholar]
  22. Locht H., Kihlström E., Lindström F. D. Reactive arthritis after Salmonella among medical doctors--study of an outbreak. J Rheumatol. 1993 May;20(5):845–848. [PubMed] [Google Scholar]
  23. Mattila L., Leirisalo-Repo M., Pelkonen P., Koskimies S., Granfors K., Siitonen A. Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection. J Infect. 1998 May;36(3):289–295. doi: 10.1016/s0163-4453(98)94243-8. [DOI] [PubMed] [Google Scholar]
  24. Merilahti-Palo R., Söderström K. O., Lahesmaa-Rantala R., Granfors K., Toivanen A. Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis. Ann Rheum Dis. 1991 Feb;50(2):87–90. doi: 10.1136/ard.50.2.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Peterson M. C. Rheumatic manifestations of Campylobacter jejuni and C. fetus infections in adults. Scand J Rheumatol. 1994;23(4):167–170. doi: 10.3109/03009749409103055. [DOI] [PubMed] [Google Scholar]
  26. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  27. Sairanen E., Paronen I., Mähönen H. Reiter's syndrome: a follow-up study. Acta Med Scand. 1969 Jan-Feb;185(1-2):57–63. doi: 10.1111/j.0954-6820.1969.tb07298.x. [DOI] [PubMed] [Google Scholar]
  28. Schumacher H. R., Jr, Magge S., Cherian P. V., Sleckman J., Rothfuss S., Clayburne G., Sieck M. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Immunocytochemical identification of chlamydial antigen in patients with early disease. Arthritis Rheum. 1988 Aug;31(8):937–946. doi: 10.1002/art.1780310801. [DOI] [PubMed] [Google Scholar]
  29. Sieper J., Fendler C., Laitko S., Sörensen H., Gripenberg-Lerche C., Hiepe F., Alten R., Keitel W., Groh A., Uksila J. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum. 1999 Jul;42(7):1386–1396. doi: 10.1002/1529-0131(199907)42:7<1386::AID-ANR12>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  30. Thomson G. T., Alfa M., Orr K., Thomson B. R., Olson N. Secretory immune response and clinical sequelae of Salmonella infection in a point source cohort. J Rheumatol. 1994 Jan;21(1):132–137. [PubMed] [Google Scholar]
  31. Toivanen A. Bacteria-Triggered reactive arthritis: implications for antibacterial treatment. Drugs. 2001;61(3):343–351. doi: 10.2165/00003495-200161030-00003. [DOI] [PubMed] [Google Scholar]
  32. Toivanen A., Granfors K., Lahesmaa-Rantala R., Leino R., Ståhlberg T., Vuento R. Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects. Immunol Rev. 1985 Aug;86:47–70. doi: 10.1111/j.1600-065x.1985.tb01137.x. [DOI] [PubMed] [Google Scholar]
  33. Toivanen A., Yli-Kerttula T., Luukkainen R., Merilahti-Palo R., Granfors K., Seppälä J. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol. 1993 May-Jun;11(3):301–307. [PubMed] [Google Scholar]
  34. Wattiaux M. J., Bourgeois P., Picard O., Bennani M., Thomas M., Desproges-Gotteron R., Kahn M. F., Imbert J. C. Two familial cases of malignant Reiter's syndrome. Clin Exp Rheumatol. 1989 Sep-Oct;7(5):541–545. [PubMed] [Google Scholar]
  35. Yli-Kerttula T., Luukkainen R., Yli-Kerttula U., Möttönen T., Hakola M., Korpela M., Sanila M., Parviainen J., Uksila J., Vainionpä R. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis. 2000 Jul;59(7):565–570. doi: 10.1136/ard.59.7.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Yli-Kerttula T., Möttönen T., Toivanen A. Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one. J Rheumatol. 1997 Oct;24(10):2047–2050. [PubMed] [Google Scholar]
  37. Yli-Kerttula T., Tertti R., Toivanen A. Ten-year follow up study of patients from a Yersinia pseudotuberculosis III outbreak. Clin Exp Rheumatol. 1995 May-Jun;13(3):333–337. [PubMed] [Google Scholar]
  38. Zhang Y., Gripenberg-Lerche C., Söderström K. O., Toivanen A., Toivanen P. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model. Arthritis Rheum. 1996 Jul;39(7):1238–1243. doi: 10.1002/art.1780390725. [DOI] [PubMed] [Google Scholar]
  39. Zhang Y., Toivanen A., Toivanen P. Experimental Yersinia-triggered reactive arthritis: effect of a 3-week course of ciprofloxacin. Br J Rheumatol. 1997 May;36(5):541–546. doi: 10.1093/rheumatology/36.5.541. [DOI] [PubMed] [Google Scholar]
  40. van der Linden S., Valkenburg H. A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984 Apr;27(4):361–368. doi: 10.1002/art.1780270401. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES